The abrupt resignation of Dr. Jose Baselga in September 2018 laid bare the corrupt influence wielded by drug and medical device-makers over medical research and the unintended consequences of deregulation. Baselga, the now-former chief scientific officer of Memorial Sloan Kettering Cancer Center, resigned after reporting by ProPublica and The New York Times revealed that he repeatedly failed to properly …
Please sign in to continue.
Become a valued Chicago Lawyer subscriber today and receive:
- 12 monthly print editions mailed.
- Access to chicagolawyermagazine.com and our e-edition.
- Bimonthly news and informational emails.
- Special editions such as Forty Under 40, Practice Resource Guides and much, much more!.
Call (312) 644-2394 or subscribe now.